EC approves Novo Holding’s $16.5bn acquisition of Catalent
EC said the transaction, expected to be closed by the end of this year, would not raise competition concerns in the European Economic Area (EEA), including the 27 EU countries,...
A leading resource for the Pharmaceutical industry since 2002
EC said the transaction, expected to be closed by the end of this year, would not raise competition concerns in the European Economic Area (EEA), including the 27 EU countries,...
Societal polarisation presents significant challenges for the pharmaceutical industry, affecting regulatory landscapes, public trust, innovation, and market dynamics
Effects of interstate armed conflicts on the pharmaceutical industry
Unveiling the impact of misinformation and disinformation in the pharmaceutical industry
The ripple effects of inflation on the pharmaceutical industry
Extreme weather events: The implications for the pharmaceutical industry